Addressing hepatic metastases in ovarian cancer: Recent advances in treatment algorithms and the need for a multidisciplinary approach

The lifetime risk for ovarian cancer incidence is 1.39% and the lifetime risk of death is 1.04%. Most ovarian cancer patients are diagnosed at advanced stages (III, IV) because there were no specific symptoms or existing screening tests. Liver metastases have been found in up to 50% of patients dyin...

Descripción completa

Detalles Bibliográficos
Autores principales: Adamopoulou, Konstantina, Gkamprana, Athanasia M, Patsouras, Konstantinos, Halkia, Evgenia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473491/
https://www.ncbi.nlm.nih.gov/pubmed/34630879
http://dx.doi.org/10.4254/wjh.v13.i9.1122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473491/
https://www.ncbi.nlm.nih.gov/pubmed/34630879
http://dx.doi.org/10.4254/wjh.v13.i9.1122

Ejemplares similares